The NAFLD fibrosis score
2007 · Hepatology · 3,116 citations
https://doi.org/10.1002/hep.21496
K
Keith D. Lindor
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
655
Papers
55.3K
Citations
117
h-index
391
i10-index
Keith D. Lindor is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Liver Diseases and Immunity & Liver Disease Diagnosis and Treatment & Pediatric Hepatobiliary Diseases and Treatments. The author has an h-index of 117, co-authored 557 publications.
ORCID: 0000-0003-1046-5621Papers by this author
worksPatient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
2017 · Gastroenterology · 505 citations
https://doi.org/10.1053/j.gastro.2017.02.038
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
2017 · Hepatology · 418 citations
https://doi.org/10.1002/hep.29721
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis
2003 · Journal of Hepatology · 215 citations
https://doi.org/10.1016/s0168-8278(03)00192-2
Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices
2019 · Clinical Gastroenterology and Hepatology · 91 citations
https://doi.org/10.1016/j.cgh.2019.01.025
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis
2021 · Hepatology International · 72 citations
https://doi.org/10.1007/s12072-021-10170-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat